Search Results for: COVID-19 research
2020, the year COVID-19 tuned us into science: Part 3
Since the arrival of a new, unknown, dangerous virus in January, we entered the realm of COVID-19 science. Part 1 …Read More
2020, the year COVID-19 tuned us into science: Part 2
Thanks — or no thanks — to COVID-19, 2020 has been a year in which science became a household topic …Read More
2020, the year COVID-19 tuned us into science: Part 1
On January 9, the World Health Organization announced a mysterious pneumonia in Wuhan, China. Few people knew it was the …Read More
It’s personal: How the Boston Children’s progeria research community brought new life to an old drug
In late November, the U.S. Food and Drug Administration (FDA) approved a repurposed cancer drug called lonafarnib to treat Hutchinson-Gilford …Read More
How does the placenta protect unborn babies from COVID-19?
Evidence has shown that pregnancy is a risk factor for severe illness in women with COVID-19. A recent CDC study …Read More
The new COVID-19 vaccines: Will they be safe?
Just within the past week, pharmaceutical companies have announced encouraging news about two COVID-19 vaccines in the final development phase. …Read More
Testing the COVID-19 vaccines in kids: Is it safe?
The drug company Pfizer recently announced they had opened their clinical trial of the COVID-19 vaccine to teens as young …Read More
A COVID-19 DNA nanoswitch: A new kind of test for a new kind of virus
When the COVID-19 pandemic shut down research laboratories across the country, several labs at Boston Children’s Hospital geared up, including …Read More
COVID-19 and sports: Is it safe to play again?
It was hard on athletes when COVID-19 forced sports to shut down last spring, but at least everyone was in …Read More
A diabetes drug with a potential side benefit: Reduced COVID-19 mortality
In 2006, the Food and Drug Administration approved the drug sitagliptin to lower blood sugar in type 2 diabetes. Now, …Read More